These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 34624752)

  • 1. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
    Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X
    Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
    Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
    Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
    Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
    Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y; Xie J
    J Nanobiotechnology; 2021 Jun; 19(1):182. PubMed ID: 34127005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Responsive Supramolecular Polymeric Nanomedicine for Self-Cascade Amplified Cancer Immunotherapy.
    Hu W; Ye B; Yu G; Yang H; Wu H; Ding Y; Huang F; Wang W; Mao Z
    Adv Sci (Weinh); 2024 May; 11(20):e2305382. PubMed ID: 38493499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.
    Wang M; Wu M; Liu X; Shao S; Huang J; Liu B; Liang T
    Adv Sci (Weinh); 2022 Oct; 9(29):e2202914. PubMed ID: 35981886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
    Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
    Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
    Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
    ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Pronged Attack: pH-Driven Membrane-Anchored NIR Dual-Type Nano-Photosensitizer Excites Immunogenic Pyroptosis and Sequester Immune Checkpoint for Enhanced Prostate Cancer Photo-Immunotherapy.
    Wang H; He Z; Gao Y; Feng D; Wei X; Huang Y; Hou J; Li S; Zhang W
    Adv Sci (Weinh); 2023 Oct; 10(28):e2302422. PubMed ID: 37544896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade Immune Activation of Self-Delivery Biomedicine for Photodynamic Immunotherapy Against Metastatic Tumor.
    Zheng RR; Zhao LP; Yang N; Chen ZX; Kong RJ; Huang CY; Rao XN; Chen X; Cheng H; Li SY
    Small; 2023 Jan; 19(3):e2205694. PubMed ID: 36366925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual-pathway pyroptosis inducer based on Au-Cu
    Yan X; Chen C; Ren Y; Su T; Chen H; Yu D; Huang Y; Chao M; Wu G; Jiang G; Gao F
    Acta Biomater; 2024 Oct; 188():329-343. PubMed ID: 39278301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
    Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
    ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
    Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
    Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
    Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
    J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
    Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
    Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone.
    Zhou S; Shang Q; Wang N; Li Q; Song A; Luan Y
    J Control Release; 2020 Dec; 328():617-630. PubMed ID: 32976902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.
    Johnson TS; Mcgaha T; Munn DH
    Adv Exp Med Biol; 2017; 1036():91-104. PubMed ID: 29275467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Immunotherapy and Photo-pyroptosis as Novel Anticancer Strategy.
    Dao A; Yadav AK; Wei L; Banerjee S; Huang H
    Chembiochem; 2022 Aug; 23(15):e202200201. PubMed ID: 35438233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment.
    Li Q; Liu J; Fan H; Shi L; Deng Y; Zhao L; Xiang M; Xu Y; Jiang X; Wang G; Wang L; Wang Z
    Biomaterials; 2021 Feb; 269():120388. PubMed ID: 33172606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.